tiprankstipranks
Trending News
More News >
PharmX Technologies Limited (AU:PHX)
ASX:PHX
Australian Market

PharmX Technologies (PHX) Financial Statements

Compare
2 Followers

PharmX Technologies Financial Overview

PharmX Technologies's market cap is currently AU$82.43M. The company's EPS TTM is AU$-0.001; its P/E ratio is -78.13; PharmX Technologies is scheduled to report earnings on February 24, 2026, and the estimated EPS forecast is AU$―. See an overview of income statement, balance sheet, and cash flow financials.
Jun 24
Income Statement
Total RevenueAU$ 7.32M
Gross ProfitAU$ 5.96M
Operating IncomeAU$ -1.42M
EBITDAAU$ 1.39M
Net IncomeAU$ -264.00K
Balance Sheet
Cash & Short-Term InvestmentsAU$ 4.17M
Total AssetsAU$ 18.82M
Total DebtAU$ 894.00K
Net DebtAU$ -3.28M
Total LiabilitiesAU$ 2.90M
Stockholders' EquityAU$ 15.93M
Cash Flow
Free Cash FlowAU$ -8.16M
Operating Cash FlowAU$ -8.13M
Investing Cash FlowAU$ -695.00K
Financing Cash FlowAU$ -136.00K
Currency in AUD

PharmX Technologies Earnings and Revenue History

PharmX Technologies Debt to Assets

PharmX Technologies Cash Flow

PharmX Technologies Forecast EPS vs Actual EPS